Saxenda is approved for: Adults Adults with obesity (BMI of 30 kg/m or greater) Adults who are overweight (BMI of 27 kg/m or greater) and have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol Children aged 12 and older Adolescents with obesity who weigh more than 60 kg (132 pounds) Limitations of use Saxenda should not be used together with other medicines that contain liraglutide, such as Victoza, or with any other GLP-1 receptor agonist, such as Ozempic, Wegovy, or Trulicity The safety and effectiveness of Saxenda in children aged 12 to 17 years who have type 2 diabetes have not been established
canephora robusta, seed, 45% chlorogenic acids): 200 mg L-carnitine L-tartrate: 100 mg L-theanine: 100 mg Cocoa extract (Theobroma cacao, seed, 6% theobromine): 100 mg Black pepper extract (Piper nigrum, fruit, 95% piperine): 5 mg Cayenne pepper (Capsicum annuum, fruit): 5 mg *RI - Reference Intake Ingredients: Veggie capsule (hypromellose, titanium dioxide), cellulose, silicon dioxide, magnesium stearate, caffeine anhydrous, green coffee extract, L-carnitine L-tartrate, L-theanine, cocoa extract, black pepper extract, cayenne pepper
Archives of facial plastic surgery, 2005, 7(1): 27-31
This systemic reach makes the BPC-157 TB-500 blend particularly relevant for research involving diffuse or multi-site tissue damage
Whether a given compound is offered branded or compounded, and injectable or oral, depends on each brand's current catalog
They can also provide information on potential side effects and interactions with other medications
